Cargando…

Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries

[Image: see text] High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide–alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehrtz, Paul, Marom, Shir, Bührmann, Mike, Hardick, Julia, Kleinbölting, Silke, Shraga, Amit, Dubiella, Christian, Gabizon, Ronen, Wiese, Jan N., Müller, Matthias P., Cohen, Galit, Babaev, Ilana, Shurrush, Khriesto, Avram, Liat, Resnick, Efrat, Barr, Haim, Rauh, Daniel, London, Nir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376956/
https://www.ncbi.nlm.nih.gov/pubmed/35912476
http://dx.doi.org/10.1021/acs.jmedchem.1c02206
_version_ 1784768243117850624
author Gehrtz, Paul
Marom, Shir
Bührmann, Mike
Hardick, Julia
Kleinbölting, Silke
Shraga, Amit
Dubiella, Christian
Gabizon, Ronen
Wiese, Jan N.
Müller, Matthias P.
Cohen, Galit
Babaev, Ilana
Shurrush, Khriesto
Avram, Liat
Resnick, Efrat
Barr, Haim
Rauh, Daniel
London, Nir
author_facet Gehrtz, Paul
Marom, Shir
Bührmann, Mike
Hardick, Julia
Kleinbölting, Silke
Shraga, Amit
Dubiella, Christian
Gabizon, Ronen
Wiese, Jan N.
Müller, Matthias P.
Cohen, Galit
Babaev, Ilana
Shurrush, Khriesto
Avram, Liat
Resnick, Efrat
Barr, Haim
Rauh, Daniel
London, Nir
author_sort Gehrtz, Paul
collection PubMed
description [Image: see text] High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide–alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography–mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter.
format Online
Article
Text
id pubmed-9376956
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93769562022-08-16 Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries Gehrtz, Paul Marom, Shir Bührmann, Mike Hardick, Julia Kleinbölting, Silke Shraga, Amit Dubiella, Christian Gabizon, Ronen Wiese, Jan N. Müller, Matthias P. Cohen, Galit Babaev, Ilana Shurrush, Khriesto Avram, Liat Resnick, Efrat Barr, Haim Rauh, Daniel London, Nir J Med Chem [Image: see text] High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide–alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography–mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter. American Chemical Society 2022-07-30 2022-08-11 /pmc/articles/PMC9376956/ /pubmed/35912476 http://dx.doi.org/10.1021/acs.jmedchem.1c02206 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Gehrtz, Paul
Marom, Shir
Bührmann, Mike
Hardick, Julia
Kleinbölting, Silke
Shraga, Amit
Dubiella, Christian
Gabizon, Ronen
Wiese, Jan N.
Müller, Matthias P.
Cohen, Galit
Babaev, Ilana
Shurrush, Khriesto
Avram, Liat
Resnick, Efrat
Barr, Haim
Rauh, Daniel
London, Nir
Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
title Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
title_full Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
title_fullStr Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
title_full_unstemmed Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
title_short Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries
title_sort optimization of covalent mkk7 inhibitors via crude nanomole-scale libraries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376956/
https://www.ncbi.nlm.nih.gov/pubmed/35912476
http://dx.doi.org/10.1021/acs.jmedchem.1c02206
work_keys_str_mv AT gehrtzpaul optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT maromshir optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT buhrmannmike optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT hardickjulia optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT kleinboltingsilke optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT shragaamit optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT dubiellachristian optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT gabizonronen optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT wiesejann optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT mullermatthiasp optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT cohengalit optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT babaevilana optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT shurrushkhriesto optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT avramliat optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT resnickefrat optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT barrhaim optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT rauhdaniel optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries
AT londonnir optimizationofcovalentmkk7inhibitorsviacrudenanomolescalelibraries